About Institut Virion-Serion
Institut Virion-Serion is a company based in Wurzburg (Germany) founded in 1978 by Brigitte Hermann, Judith Striker, and Gerhard Hermann was acquired by HQIB in February 2024. Institut Virion-Serion offers products and services including SERION ELISA classic, SERION antigens, SERION antibodies, and SERION plasma. Institut Virion-Serion operates in a competitive market with competitors including Inflammatix, Karius, MeMed, Visby Medical and GenMark Diagnostics, among others.
- Headquarter Wurzburg, Germany
- Founders Brigitte Hermann, Judith Striker, Gerhard Hermann
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Institut Virion\Serion Gmbh
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Institut Virion-Serion
Institut Virion-Serion offers a comprehensive portfolio of products and services, including SERION ELISA classic, SERION antigens, SERION antibodies, and SERION plasma.
Immunoassays for detecting antibodies against human pathogens.
Antigens for assay development and infectious disease diagnostics.
Monoclonal antibodies for IVD calibrators and controls.
Plasma products for creating diagnostic calibrators.
Funding Insights of Institut Virion-Serion
Detailed funding history for Institut Virion-Serion
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Institut Virion-Serion
Institut Virion-Serion has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include HQIB.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A long-term oriented industrial holding company is managed by HQIB.
|
Locked | Locked | Locked |
Investor details for Institut Virion-Serion
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Institut Virion-Serion
Investment portfolio details for Institut Virion-Serion
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Institut Virion-Serion
Detailed financials for Institut Virion-Serion
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Institut Virion-Serion Comparisons
Peer comparison for Institut Virion-Serion
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Institut Virion-Serion
Institut Virion-Serion operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inflammatix, Karius, MeMed, Visby Medical and GenMark Diagnostics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of diagnostic solutions for systemic infections
|
|
| Locked | Locked | Locked |
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
|
|
| Locked | Locked | Locked |
Provider of machine learning based diagnostic solutions for infectious diseases
|
|
| Locked | Locked | Locked |
Portable PCR diagnostics for infectious diseases are developed.
|
|
| Locked | Locked | Locked |
Instruments and test panels for multiplexed molecular diagnostics are provided.
|
|
| Locked | Locked | Locked |
Diagnostic technologies for infectious, cancer, and neurological diseases are developed.
|
Detailed competitors of Institut Virion-Serion
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Institut Virion-Serion
Complete news archive for Institut Virion-Serion
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Institut Virion-Serion
Institut Virion-Serion was founded in 1978.
Institut Virion-Serion is headquartered in Wurzburg, Germany. It is registered at Wurzburg, Bavaria, Germany.
Institut Virion-Serion is engaged in development and marketing of in-vitro diagnostic products for infectious diseases. The company offers wide range of products for the serological detection of infectious diseases including SERION ELISA classic (allows qualitative and quantitative antibody detection), SERION ELISA antigen immunoassays, SERION ELISA control, SERION Multianalyt technology (fluorescence immunoassays)- is a particle based technology that allows simultaneous quantification of multiple parameters, SERION neonatal for the detection of antibodies respiratory infections in newborns, and complement fixation test (CFT). In addition, the company offers a four-plate and a two-plate benchtop ELISA analyzers. The company offers its product through a team of sales representatives.
Institut Virion-Serion's top competitors include Visby Medical, Inflammatix and MeMed.
Institut Virion-Serion offers SERION ELISA classic, SERION antigens, SERION antibodies, and SERION plasma.
Institut Virion-Serion has 1 investor. Key investors include HQIB.